The active ingredient used in injection lipolysis is an important liver nutrient and a liver-protective substance that has been known for many years. It is also used in Germany for preventing fat embolism (blockages) in the blood. It has, as yet, not been approved by political health authorities for use in injection lipolysis. However, this is not the only therapy in which a substance is applied in a so-called “off-label use”. One of the best-known examples for this kind of use is that of botox injections for the treatment of wrinkles, which is used on millions of patients every year. In all countries in which the active substance is not yet approved for lipolyis, the treating physician can – completely legally – write out a prescription for the patient and have the substance produced by a pharmacist.
On the basis of the long-standing experience of the members of NETWORK Lipolysis, no health risks have been found. The active substance itself and its metabolism have been very thoroughly studied and documented in connection with the treatment of fat embolism with intravenous injections. For subcutaneous injection into the fatty tissue, we so far only have our own practical observations to rely on – but these are based on a very large number of treatments. The only side-effects that have occurred after treatment are temporary reddening of the treated area, swelling with sensitivity to pressure and sensation similar to muscle ache after over-exertion, and, in some patients, bruising. After a few days, however, the treated region is symptom-free. Please note, however, that the side-effects detailed here are only those that occur in nearly all patients. Other side-effects can also rarely occur, though these are of a predominantly individual nature. Therefore, never be satisfied simply with being informed of the general side-effects outlined above, but also make sure to be informed of the possible individual side effects. In other words, always hold a detailed consultation with an experienced ISL doctor to discuss the general and individual side-effects and risks.